Optimised generation of iPSC-derived macrophages and dendritic cells that are functionally and transcriptionally similar to their primary counterparts

S Monkley, JK Krishnaswamy, M Göransson… - PLoS …, 2020 - journals.plos.org
Induced pluripotent stem cells (iPSC) offer the possibility to generate diverse disease-
relevant cell types, from any genetic background with the use of cellular reprogramming and …

Differentiation of Human‐Induced Pluripotent Stem Cells to Macrophages for Disease Modeling and Functional Genomics

J Shi, C Xue, W Liu, H Zhang - Current protocols in stem cell …, 2019 - Wiley Online Library
Macrophages play important roles in many diseases. We describe a protocol and the
associated resources for the differentiation of human induced pluripotent stem cell‐derived …

Induced pluripotent stem cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy

C Horton, TJ Davies, P Lahiri, P Sachamitr… - Stem Cells, 2020 - academic.oup.com
Cell types differentiated from induced pluripotent stem cells (iPSCs) are frequently arrested
in their development program, more closely resembling a fetal rather than an adult …

Production and characterization of human macrophages from pluripotent stem cells

M Lopez-Yrigoyen, A May, T Ventura, H Taylor… - JoVE (Journal of …, 2020 - jove.com
Macrophages are present in most vertebrate tissues and comprise widely dispersed and
heterogeneous cell populations with different functions. They are key players in health and …

[HTML][HTML] Differentiation of human induced pluripotent stem cells to authentic macrophages using a defined, serum-free, open-source medium

A Vaughan-Jackson, S Stodolak, KH Ebrahimi… - Stem Cell Reports, 2021 - cell.com
Human induced pluripotent stem cells (iPSCs) and macrophages derived from them are
increasingly popular tools for research into both infectious and degenerative diseases …

Induced pluripotent stem cell (iPSCs) and their application in immunotherapy

Z Jiang, Y Han, X Cao - Cellular & molecular immunology, 2014 - nature.com
The ever-improving technology to generate induced pluripotent stem cells (iPSCs) has
increased their potential use as novel candidates for disease modeling, drug screening …

High-yield human induced pluripotent stem cell-derived monocytes and macrophages are functionally comparable with primary cells

D Cui, A Franz, SA Fillon, L Jannetti… - Frontiers in Cell and …, 2021 - frontiersin.org
Macrophages are pivotal effectors of host immunity and regulators of tissue homeostasis.
Understanding of human macrophage biology has been hampered by the lack of reliable …

In vitro immunogenicity of undifferentiated pluripotent stem cells (PSC) and derived lineages

S Kadereit, A Trounson - Seminars in Immunopathology, 2011 - Springer
The observation that embryonic stem cells (ESCs) expressed reduced levels of major
histocompatibility (MHC) class I genes, no MHC class II or costimulatory molecules …

New lessons learned from disease modeling with induced pluripotent stem cells

TT Onder, GQ Daley - Current opinion in genetics & development, 2012 - Elsevier
Cellular reprogramming and generation of induced pluripotent stem cells (iPSCs) from adult
cell types have enabled the creation of patient-specific stem cells for use in disease …

Continuous human iPSC-macrophage mass production by suspension culture in stirred tank bioreactors

M Ackermann, A Rafiei Hashtchin, F Manstein… - Nature protocols, 2022 - nature.com
Macrophages derived from human induced pluripotent stem cells (iPSCs) have the potential
to enable the development of cell-based therapies for numerous disease conditions. We …